Doyle Thomas James

EDGAR CIK 0001910331

Kura Oncology, Inc. - KURA

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
Officer
SVP, Finance & Accounting
Direct Buys
0
$0
0 Shares
Direct Sells
1
($38,958)
-4,949 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
01/28/2025
01/28/2025
Sell
-4,949 @ $7.87
 ($38,958) 88,193 (-5.31%) Direct